成都市高新区药工医药生物技术研究所

Chengdu Yaogong Pharmaceutical Biotechnology Research Institute is a specialized biotechnology research entity located in the Chengdu Hi-tech Zone, Sichuan Province, China. The institute is most notable for its significant role in the research and development of the world's first oral recombinant Helicobacter pylori vaccine, which was developed in collaboration with the Third Military Medical University. Under the leadership of renowned scientist Professor Zou Quanming, the institute focuses on the prevention and treatment of infectious diseases through innovative vaccine technology. Its core competencies include recombinant protein expression, vaccine formulation, and clinical-stage R&D for gastrointestinal and bacterial pathogens. The institute serves as a critical hub for translating academic research into commercializable biopharmaceutical products.